Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Citizen Meds vs Ilant Health

Citizen Meds
Graded #245

Higher grade

vs+7.200000000000003
Ilant Health
Graded #407

Lower grade

The verdict

Citizen Meds takes it — 64/100 to 56.8/100.

Citizen Meds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Citizen Meds is a GLP-1/weight-loss injection provider offering semaglutide.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueCitizen Meds +26
71
45
Dose & formulationCitizen Meds +14
54
40
Clinical oversightIlant Health +4
79
83
Labs & monitoringIlant Health +9
52
61
FulfillmentEven
62
62
Contract termsEven
55
55
Citizen Meds · left barIlant Health · right bar

The numbers

MetricCitizen MedsIlant Health
WeighScore64/10056.8/100
GradeCC
Scorecard rank#245#407
Semaglutide$125/mo (0.25 mg dose, compounded)Not disclosed
Tirzepatide$185/mo (2.5 mg dose, first-month rate, compounded)Not disclosed
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Citizen Meds

Graded #245 · C

Strengths

  • Semaglutide confirmed from product listings
  • New-patient discount available (code NEWPATIENT10)

Where it loses points

  • No visible LegitScript or PCAB accreditation
  • State availability not disclosed
  • About page returns a 404
  • Limited overall transparency
Ilant Health

Graded #407 · C

Strengths

  • Value-based, outcomes-driven obesity care model
  • Includes GLP-1 medications with transparent drug pricing for sponsors
  • Care team of board-certified obesity providers and behavioral specialists
  • Dietitians and peer navigators support adherence
  • Data-driven stratification targets the right interventions

Where it loses points

  • Distributed via employers and health plans, not direct cash-pay
  • Individuals generally cannot enroll without sponsor coverage
  • No public consumer pricing for GLP-1
  • Access gated behind organizational buyers
  • Not suited to consumers wanting direct-to-door GLP-1

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard